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Introduction 
 
According to international statistics the prevalence of arrhythmias is 53 per 1000. 
In Hungary approximately 500 000 people suffer from arrhythmia. Arrhythmia is 
an important source of mortality in European countries and in Hungary too. 50 to 
100 sudden unexpected cardiac deaths occur per 100 000 population every year. 
All disturbances of rhythm resulted from abnormalities in electrical activity of 
myocytes, because of the action potential (AP) morphology is altered or the 
activity of ion channels are abnormal. The abnormal activity causes abnormality in 
impulse initiation and/or abnormality in impulse propagation. Many of the 
antiarrhythmic drugs that are used to treat cardiac arrhythmias have their action on 
ion currents flowing transmembrane ion channels, and changes the process of 
repolarization, refractory period or the velocity of stimulus propagation. However, 
antiarrhythmic drugs have proarrhythmic (facilitation of new arrhythmias) effects. 
Cardiac cation channels have been widely touted as the target of choice for the 
treatment of cardiac arrhythmia. However, drugs that target these channels have 
improved the survival of cardiac patients only moderately, highlighting a need for 
fresh approaches to antiarrhythmic therapy. Care must be taken applying 
antiarrhythmic drugs, because in several case proarrhythmic effects were reported. 
New targets, including Cl
−
 channels, have thus been identified as potentially 
important sites of action for future antiarrhythmic agents. The role and importance 
of cardiac Ca
2+
-activated Cl
−
 current (ICl(Ca)) in shaping the AP is poorly 
understood. Previous studies have been investigated the role of Cl
−
 current in 
formation of delayed afterdepolarization and it has been demonstrated that Ca
2+
-
activated Cl
−
 current (ICl(Ca)) may be involved in development of arrhythmias. 
Therefore, understanding the role of Ca
2+
-activated Cl
−
 current in shaping AP may 
create an opportunity to develop therapeutic agents against arrhythmias. 
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Aims 
The exact role of Cl
−
 channels in cardiac electrical activity is unclear. ICl(Ca) may 
contribute to the repolarization as Ito2, however the true profile of ICl(Ca) during 
ventricular AP is poorly understood. Our aims were: 
- to confirm the presence of ICl(Ca) in canine left ventricular myocytes;  
- to compare the effects of two IClCa inhibitors, 9-anthracene carboxylic 
acid (9-AC) and 4,4’-diisothiocyanostilbene-2,2’-disulfonic acid (DIDS); 
- to explore whether DIDS or 9-AC is preferable to study ICl(Ca); 
- to study the Ca2+- and voltage dependence of ICl(Ca); 
- to characterize ICl(Ca) profiles under actual action potential; 
- to reveal the expression pattern of a ICl(Ca) potential channel proteins, 
TMEM16A and Bestrophin-3 in human and canine myocytes; 
- to visualize cellular appearance and co-localization of TMEM16A and 
Bestrophin-3 with each other as well as with pore forming subunit of L-
type Ca
2+
 channels (Cav1.2).  
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Materials and methods 
Electrophysiology 
Experiments were performed using enzymatically isolated canine left ventricular 
myocytes. All animal handling and laboratory procedures conform to the Guide for 
the Care and Use of Laboratory Animals published by the US National Institutes of 
Health, and to our Institutional Animal Care and Use Committee approved 
protocols. Cell isolation was carried out by enzymatic dispersion using the segment 
perfusion technique. Action potentials (AP) were recorded using current clamp 
mode of patch clamp technique. Transmembrane ionic currents were recorded 
using the whole-cell configuration of the patch-clamp technique and action 
potential voltage-clamp (APVC) techniques. ICl(Ca) was defined as an inhibitor-
sensitive current (I9-AC or IDIDS) obtained by pharmacological subtraction. Ion 
currents were normalized to cell capacitance. 
During APVC experiments sequential dissection experiments were conducted. APs 
were recorded in current-clamp mode from the myocytes superfused with Tyrode 
solution and were used as a command in voltage-clamp mode. All experiments 
except for molecular biological techniques were applied at 37 °C. 
 
Isolation of left ventricular myocytes from non-diseased human donor hearts 
Human hearts were obtained from organ donors whose non-diseased hearts were 
explanted to obtain pulmonary and aortic valves for transplant surgery. The 
investigations conformed to the principles of the Declaration of Helsinki. 
Experimental protocols were approved by the Ethical Review Board of the 
Medical Center of the University of Szeged and by the Scientific and Research 
Ethical Committee of the Medical Scientific Board at the Hungarian Ministry of 
Health. Single, isolated left ventricular myocytes were used for 
immunocytochemistry and confocal imaging. 
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Intracellular Ca
2+
 concentration and cell shortening measurement 
Single cell shortening was recorded by optical edge detection, while changes in 
intracellular free Ca
2+
 concentration ([Ca
2+
]i) were assessed by FURA-2-AM. 
Immunocytochemistry and confocal imaging  
Immunolabeling for Cav1.2, TMEM16A and Bestrophin-3 was performed in 
isolated canine left ventricular myocytes and isolated human left ventricular 
myocytes. Cells were probed with anti-TMEM16A (rabbit, 1:200), anti-
Bestrophin-3 (goat, 1:200), anti-Cav1.2 (rabbit, 1:200) anti-ryanodine receptor 
(mouse, 1:200), or with anti-cytochrome c (mouse, 1:200) primary antibodies. The 
secondary antibody labeling was the following: biotinylated anti-rabbit, anti-mouse 
or anti-goat antibody then Streptavidine Alexa488 incubation and with Cy3 anti-
mouse or anti-rabbit labeling. To visualize the nuclei, cells were mounted with 
Vectashield mounting medium containing 4',6-diamidino-2-phenylindole (DAPI). 
The Pearson correlation coefficient was used to quantify the degree of co-
localization between fluorophores.  
Statistics 
Results are expressed as mean ± SEM values. Statistical significance of differences 
was evaluated using one-way ANOVA followed by Student's t-test. Differences 
were considered significant when p was less than 0.05. 
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Results 
Calcium-activated chloride current measured as either DIDS- or 9-AC-sensitive 
current is identical during conventional voltage-clamp recording 
Conventional voltage-clamp technique was applied to investigate ICl(Ca) in canine 
left ventricular cardiomyocytes. The current was measured with the application of 
the two well-known inhibitors: 0.2 mmol/l DIDS or 0.5 mmol/l 9-AC. Cells were 
clamped to -40 mV as the holding potential and the current was activated by 
200 ms long voltage steps applied between -100 and +100 mV with 20 mV 
increments in every 5 sec. DIDS- or 9-AC-sensitive current was determined by 
deducting the current traces measured in the presence of the inhibitor from those 
recorded in the absence of them and normalized to cell capacitance. Both DIDS-
sensitive and 9-AC-sensitive current traces showed rapid activation and reached 
their peak values within approximately 15 ms. Interestingly, not only the 
activation, but the decay of the current was also fairly rapid. The current decreased 
to near zero 100 ms after the onset of the depolarizing pulse. Currents activated at 
potentials higher than -40 mV and its current-voltage relationship had a bell-
shaped curve with a peak value at +60 mV. The current-voltage relationships in 
case of the two tested drugs were practically identical.  
 
Comparison of the effects of DIDS and 9-AC on the action potential measured with 
sharp microelectrode 
Current-clamp studies were conducted in canine left ventricular cardiomyocytes 
where the actions on various parameters of the AP were determined. APs were 
recorded at 5 different steady-state cycle lengths in control condition. This was 
followed by the application of either 0.2 mmol/l DIDS or 0.5 mmol/l 9-AC. After 
the changes induced by the inhibitors reached a steady level (usually within 7-
8 min) the AP measurements at the different cycle lengths were repeated. As the 
last step, the washout of the inhibitors was performed to test the reversibility of the 
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changes. The contours of the APs were modified by the two inhibitors in a similar 
fashion except the upstroke of the AP. AP duration was determined at the level of 
90 % repolarization (APD90) and increased by both inhibitors in a similarly, 
reverse rate-dependent manner. Phase-1 magnitude (determined as the difference 
between the membrane potential values of the peak and the deepest point of the 
notch) was reduced by both inhibitors but the cycle length dependence of the 
magnitude of this reduction was different. There was a greater reduction at long 
cycle length with 9-AC whereas the opposite was the case for DIDS, leading to a 
significantly greater reduction at 2 and 5 s long cycle lengths compared to that seen 
with 9-AC. Both the amplitude of the AP and the maximal rate of the 
depolarization (Vmax) were reduced by only DIDS whereas 9-AC did not influence 
these parameters. The values of the resting membrane potential were not altered by 
either DIDS or 9-AC. 
 
Dose-dependent effects of 9-AC on the action potential 
Current-clamp studies were continued to determine whether the previously applied 
dose of 9-AC was sufficient to achieve maximal inhibition of ICl(Ca). In these 
experiments the stimulation cycle length was 1 s and increasing concentrations of 
9-AC were applied in a cumulative manner in the range of 0.05-1 mmol/l. It took 
7-8 min to reach steady-state actions of the inhibitor, therefore at least 8 min of 
perfusion period was used for each dose. The previously seen reduction of phase-1, 
increases in plateau potential and APD90 values evoked by 9-AC developed 
gradually by increasing concentrations of the inhibitor. The smallest dose evoking 
significant action on both APD90 and phase-1 values was 0.3 mmol/l. The 
application of 1 mmol/l 9-AC did not increase the changes of AP parameters 
evoked by the previous dose of 0.5 mmol/l 9-AC any further.  
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Effects of 9-AC on various cardiac cation currents measured by conventional 
voltage-clamp 
The previous current-clamp studies showed the similarities as well as the 
difference in the actions of DIDS and 9-AC on the AP of canine left ventricular 
myocytes. The reduction of AP amplitude and Vmax in case of DIDS suggested the 
inhibition of sodium channels by that inhibitor. This action was not seen with the 
application of 9-AC even in the highest applied dose (1 mmol/l). To further test the 
possible non-selective actions of 9-AC the major cation currents were measured in 
control conditions and after the application of 10 min of 0.5 mmol/l 9-AC. 
The amplitude of ICa,L was unaltered by 9-AC. In the 6 studied cells ICa,L density 
was -5.34±0.44 A/F in control condition and -5.27±0.44 A/F in the presence of 
9-AC. IKr was assessed as tail current amplitudes recorded following repolarization 
to the holding potential. The amplitude of the IKr tail currents was unaffected by 
9-AC. In the 4 studied myocytes 0.73±0.05 A/F was the density of IKr tail current 
in control whereas 0.72±0.05 A/F in the presence of 9-AC. IKs tail currents were 
also unchanged during 10 min of 9-AC perfusion in the 5 myocytes examined 
being 1.66±0.03 and 1.61±0.05 A/F in control and in 9-AC, respectively. IK1 
current was determined at the end of the pulse and showed no change in the 
6 studied cells being -18.00±1.54 and -18.36±2.16 A/F in control and in 9-AC, 
respectively. 
Ca
2+
-dependent behavior of ICl(Ca) assessed by conventional voltage-clamp 
To confirm ICl(Ca) dependence on [Ca
2+
]i, the ICl(Ca) was recorded in the presence of 
two chelators having different Ca
2+
 binding kinetics and affinity. Application of 
10 mmol/l BAPTA in the pipette solution without the addition of Ca
2+
 resulted in a 
great reduction of ICl(Ca) making the current barely detectable at any test potential 
(0.07±0.01 A/F at +60 mV). In contrast, application of 10 mmol/l EGTA in the 
pipette – although reduced ICl(Ca) (from 2.44±0.28 A/F to 1.49±0.27 A/F at 
+60 mV), – but failed to eliminate the current. In addition, the voltage-dependence 
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of ICl(Ca) in the presence and absence of EGTA was essentially similar. The Ca
2+
-
dependence of ICl(Ca) was further studied by application of a pipette solution 
designed to mimic the estimated peak systolic value of [Ca
2+
]i (1.1 µmol/l free 
Ca
2+
). This was achieved by adding BAPTA and appropriate amounts of Ca
2+
 to 
the pipette solution. The amplitude of ICl(Ca) was significantly larger when [Ca
2+
]i 
was set to 1.1 µmol/l (0.31±0.06 A/F at +60 mV) comparing to values obtained 
with 10 mmol/l BAPTA, however, it was much smaller than that measured without 
buffering [Ca
2+
]i. Applying 1 µmol/l nisoldipine, a selective inhibitor of L-type 
Ca
2+
 channels, further supported the Ca
2+
-dependent nature of ICl(Ca), since both L-
type Ca
2+
 current (ICa,L) and ICl(Ca) were eliminated by nisoldipine. These data are in 
line with the view that Ca
2+
-entry through L-type Ca
2+
 channels (in addition to the 
concomitant Ca
2+
-release from the sarcoplasmic reticulum (SR)) may be essential 
for the physiological activation of ICl(Ca). 
 
Influence of [Ca
2+
]i on ICl(Ca) recorded under action potential voltage-clamp 
(APVC) conditions 
The influence of [Ca
2+
]i buffering (by EGTA or BAPTA) as well as the preserved 
Ca
2+
-homeostasis were further studied on AP configuration and on the 
simultaneously recorded calcium transients (CaTs). ICl(Ca) and ICa,L were studied 
using their specific blockers (9-AC and nisoldipine, respectively) during the AP 
applying sequential dissection of ionic currents under conditions of APVC. CaTs 
were completely abolished when 10 mmol/l of a Ca
2+
 buffer (BAPTA or EGTA) 
was added to the pipette solution, while characteristic CaTs could be observed 
without these buffers. Under these conditions intracellular Ca
2+
-handling must be 
physiological in the absence of intracellular dialysis. In line with these results, 
unloaded cell shortening was equally abolished by either BAPTA or EGTA. Using 
BAPTA-containing pipette solution resulted in a massive prolongation of APs 
accompanied by a pronounced positive shift in the plateau potential. Phase-1 
amplitude was decreased by BAPTA in a greater extent than EGTA. In contrast to 
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BAPTA, EGTA failed to increase the duration of APs. Similarly, the profile of 
nisoldipine-sensitive current (INISO) was strongly different in the presence of the 
two Ca
2+
 buffers. BAPTA increased both the amplitude and integral of INISO 
significantly, while EGTA had no such effect on these parameters. 9-AC dissected 
an early narrow outward current having a peak value of 1.62±0.06 A/F which 
overlapped the phase-1 repolarization of the command AP (appearing 5.5±0.6 ms 
after the peak of the AP and 5.1±0.6 ms before the end of phase-1 repolarization). 
The outward peak always appeared later than the inward peak of INISO by 
6.4±0.5 ms when studied with sequential dissection on the same cells using 9-AC 
followed by nisoldipine. This outward peak of I9-AC was followed by a smaller late 
inward current reaching its maximum (−0.16±0.02 A/F) towards the end of the AP. 
BAPTA reduced significantly both the outward as well as the inward components 
of I9-AC - the outward current peak decreased nearly to zero. The effect of EGTA 
on the early outward current peak was smaller (1.17±0.09 A/F, p<0.05). These 
changes in current amplitudes were also reflected by similar alterations of current 
integrals. In summary, CaTs were completely eliminated by both Ca
2+
 buffers, 
while BAPTA but not EGTA abolished ICl(Ca) - probably due to a more effective 
buffering of [Ca
2+
]cleft. 
 
Effect of changes in [Cl
−
]i on the profile of ICl(Ca) measured with APVC 
In the APVC experiments described above, intracellular Cl
−
 concentration ([Cl
−
]i) 
was set to 47 mmol/l, yielding a Cl
−
 reversal potential of −32 mV. In this case, 
without applying any Ca
2+
 buffer, I9-AC displayed initially an early outward 
component which was followed by a late inward component having peak densities 
of 1.62±0.08 A/F and −0.16±0.03 A/F, respectively, in the 15 cells studied. To test 
and reinforce the charge carrier, the concentration of Cl
−
 in the pipette solution was 
lowered to 27 mmol/l (by replacing Cl
−
 with equimolar aspartate) setting the new 
Cl
−
 reversal potential to −47 mV. This reduction of [Cl−]i resulted in an 
enhancement of the amplitude and integral of the early outward component, while 
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the late inward component was practically eliminated. These data are considered as 
further supporting evidence that ICl(Ca) was indeed mediated by Cl
−
. 
Study of ICl(Ca) on two different stimulation frequency  
I9-AC profiles were tested at two different steady-state pacing rates under APVC 
conditions. APD90 was increased by 9-AC in a reverse-rate dependent manner. 
According to the expectations, both systolic and diastolic [Ca
2+
]i were higher when 
the preparations were stimulated at 2 Hz than at 1 Hz. In line with the larger CaT, 
the density of I9-AC as well as the total charge carried by the outward component of 
the current significantly increased when stimulatory frequency was increased from 
1 Hz to 2 Hz. 
 
ICl(Ca) is increased by enhancement of ICa,L 
As demonstrated earlier ICa,L seems to play a critical role in the activation of ICl(Ca). 
In the next experiments ICa,L was enhanced by two different mechanisms. First a 
protein kinase A-dependent phosphorylation of the calcium channel protein was 
induced by the β-adrenergic agonist isoproterenol (ISO) applied in a concentration 
of 10 nmol/l. In another set of experiments direct pharmacological stimulation of 
ICa,L was achieved by 20 nmol/l of Bay K8644. As it was confirmed with the 
recording of CaTs, both interventions resulted in an increased systolic [Ca
2+
]i, 
although ISO was more potent in this regard. ISO acted similarly to Bay K8644: 
the plateau potential was increased and phase-1 amplitude was reduced by both 
interventions. In contrast, opposite effects were observed on the duration of the 
AP, since AP was shortened by ISO while lengthened by Bay K8644. This can be 
attributed to the enhancement of IKs and IKr by ISO. IKs and IKr are not activated by 
Bay K8644 but ICa,L is expected to be increased by both 10 nmol/l ISO and 
20 nmol/l Bay K8644. ICl(Ca) was dissected by 0.5 mmol/l 9-AC using the AP 
recorded in Tyrode solution as the command signal. Both inward and outward 
peaks of I9-AC were significantly larger after pretreatment with either 10 nmol/l ISO 
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or 20 nmol/l Bay K8644 as compared to untreated controls. In addition, its profile, 
its amplitude and the total charge carried by I9-AC were similar after these 
pharmacological interventions, irrespective of the way of ICa,L enhancement. These 
results support the view that Ca
2+
-entry through the L-type calcium channels is 
critically important in the activation of ICl(Ca). 
 
Blockade of SR Ca
2+
-release by ryanodine fails to abolish ICl(Ca) 
Contribution of Ca
2+
-induced Ca
2+
 release (CICR) from the SR to the activation of 
ICl(Ca) was also examined. Superfusion of the cells with 10 μmol/l ryanodine for 
15 min greatly reduced both CaT and cell shortening. Ryanodine exposure also 
resulted in the elevation of the early plateau phase of AP. However, 0.5 mmol/l 
9-AC applied in the presence of ryanodine caused a further reduction of phase-1 
amplitude. Dissection of the corresponding ionic current by 9-AC under APVC 
conditions using the AP recorded in Tyrode solution as the command signal 
demonstrated a clear-cut ICl(Ca) in the presence of ryanodine, having its usual 
profile, although its amplitude was significantly smaller than that measured under 
control conditions. Taken together, these data give strong support to our hypothesis 
stating that CICR is not essential for, but contributes to the activation of ICl(Ca) 
which is rather influenced by transsarcolemmal Ca
2+
 entry. 
Co-expression of TMEM16A, Bestrophin-3 and Cav1.2 in the t-tubules of 
ventricular cells 
The expression pattern of potential channel protein candidates of ICl(Ca) has been 
studied using immunocytochemistry and confocal microscopy. Cav1.2, the pore 
forming subunit of ICa,L, was also assessed. The specificity of the applied 
antibodies was tested by omitting the primary antibodies during the incubation 
procedure. According to expectations, Cav1.2 protein expression was most 
abundant in the t-tubules. Importantly, strong co-localization was found between 
Cav1.2 and Bestrophin-3 indicated by the 0.74±0.03 value of the Pearson 
  
14 
 
correlation coefficient (PCC) obtained in 8 cells. TMEM16A showed a similar 
expression pattern and strong co-localization with Bestrophin-3 with a PCC of 
0.74±0.06 (n=8). In case of isolated human cells even stronger co-localization was 
detected than in case of canine cells. PCC for Cav1.2 and Bestrophin-3 yielded a 
0.84±0.02 value obtained in 18 cells. TMEM16A showed a similar expression 
pattern and strong co-localization with Bestrophin-3 with a PCC of 0.85±0.02 
(n=5). 
 
TMEM16A, Bestrophin-3, RyR and cytochrome c expression patterns in canine 
cardiomyocytes 
To exclude the possibility of an accidental co-expression and/or co-localization, 
the expression of channel protein candidates of ICl(Ca) was assessed together with 
other proteins. First the expression of cytochrome c was tested with TMEM16A. In 
spite of the recognizable striated pattern of cytochrome c expression, the co-
localization of cytochrome c and TMEM16A is unlikely as the merged image did 
not show strong overlap (PCC was 0.25±0.03 in 7 cells). Although the co-
localization of Bestrophin-3 with RyR was slightly stronger (PCC = 0.36±0.05) in 
3 cells, it was much weaker than with Cav1.2. Similarly, the co-localization of 
TMEM16A with RyR was not pronounced (PCC of 0.31±0.01) in 3 cells. 
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Discussion 
The major finding of this study is that 9-AC is a better tool to study the 
physiological role of ICl(Ca) in AP measurements compared to DIDS due to the lack 
of sodium channel inhibition in case of the former. 9-AC has also no effect on the 
other main ion currents (ICa,L, IKr, IKs, and IK1) in ventricular myocytes. ICl(Ca) was 
demonstrated to be active during the phase-1 and terminal repolarization. Our data 
gave further supporting evidence that I9-AC was Ca
2+
 activated and indeed mediated 
by Cl
−
.
 
Furthermore based on our results we can conclude that Ca
2+
-entry through 
L-type Ca
2+
 channels is sufficient for the activation of ICl(Ca) and does not require 
Ca
2+
-release from the SR through RyR. Our results demonstrate the expression of 
Bestrophin-3 and TMEM16A in both canine and human ventricular myocytes for 
the first time and the strong co-localization of Bestrophin-3 with TMEM16A and 
Cav1.2 protein. 
 
Comparing the effect of 9-AC and DIDS 
Similar current amplitudes were recorded in the whole examined voltage range by 
both drugs. This indicates that ICl(Ca) have the same magnitude measured either as 
0.2 mmol/l DIDS- or 0.5 mmol/l 9-AC-sensitive current suggesting that the 
blocking potency of the two drugs is probably the same.  
9-AC- and DIDS-sensitive current had a characteristic bell-shaped current voltage 
relationship in agreement with previous studies.  
Interestingly, not only the activation, but the decay of ICl(Ca) was also fairly rapid, 
as it decreased to near zero within 30 ms after the onset of the depolarizing pulse 
just as in previous studies. This phenomenon is quite opposite compared to that 
observed with expressed TMEM16A channels, where a maintained component 
also can be seen. This can be a result of the physiological [Ca
2+
]i changes and the 
remarkable compartmentalization, which factors are much more pronounced in 
native cardiac myocytes. 
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Comparing the actions of the two studied inhibitors on various parameters of the 
AP the most important difference was the presence or absence of Vmax reduction 
with DIDS or 9-AC, respectively. DIDS was not mentioned to reduce the Vmax 
parameter in studies performed in rabbit or in canine myocytes on the contrary to 
the result of the present study. A potential explanation can be the different species 
or experimental conditions as in the rabbit study whole-cell patch clamp was done 
instead of the more physiological conventional sharp microelectrode recording of 
the present study.  
As was demonstrated, the action of the two studied inhibitors on various AP 
parameters were largely identical (except those on Vmax and AP amplitude), 
although slight differences in phase-1 and plateau potential changes induced by the 
two drugs were seen. A greater reduction of phase-1 was seen at long cycle lengths 
(2 and 5 sec) with 9-AC. The magnitude of phase-1 depends on many ion currents 
including INa, Ito1, ICl(Ca) and ICa,L and the precise timing of their activation, 
inactivation and reactivation. DIDS was shown earlier to reduce at least 3 of these 
(INa, ICl(Ca) and ICa,L) whereas there is no evidence that 9-AC reduces any other 
current apart from ICl(Ca). Moreover, the rate-dependence of these currents can 
complicate the picture as phase-1 magnitude itself shows reverse rate-dependence 
having larger values at longer cycle lengths mainly due to two factors working 
simultaneously. First, the slow recovery from inactivation of Ito1, which decreases 
the amplitude of Ito1 at increasing heart rates, and secondly, ICa,L increases with the 
reduction of cycle length in a Ca
2+
-calmodulin protein kinase (CaMKII)-dependent 
regulatory pathway (also called as Ca
2+
 current facilitation), resulting in an earlier 
elevation of the AP plateau. Thus, the direct rate-dependent effect of 9-AC on 
phase-1 magnitude could be the result of clear-cut inhibition of ICl(Ca), which 
current is increasing at higher stimulatory frequencies as it probably follows the 
frequency-dependent properties of the Ca
2+
 entry and CaTs. While the reverse-rate 
dependent effect of DIDS on phase-1 could be attributed to an almost constant INa 
blockade, reflecting the general feature of frequency-dependence of phase-1 
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magnitude. Therefore, the difference in rate-dependent inhibition of phase-1 by the 
two studied blockers can simply be due to weaker selectivity of DIDS. The 
reverse-rate dependency of AP lengthening after the application of either DIDS or 
9-AC shows the intrinsic property of APD modulation rather than the frequency-
dependence of the blocked ion current. 
The effect of DIDS on plateau potential was small but statistically significant and 
did not depend on stimulation rate. On the contrary, 9-AC increased plateau 
potential in a direct rate-dependent manner resulting in the smaller effect of DIDS 
at short cycle lengths (0.3 and 0.5 sec). The weaker selectivity of DIDS can 
provide again a possible explanation as the reduction of ICa,L likely causes the 
reduction of plateau potential (or more precisely the smaller increase of that) 
compared to 9-AC which was actually the case at all studied cycle lengths. 
Concentration-dependent effect of 9-AC on ventricular AP was also studied. 
Concentrations of 9-AC were ranging from 0.1 to 1 mmol/l to achieve chloride 
channel inhibition in the literature. The reduction in phase-1 magnitude just as the 
lengthening of AP was saturated at 0.5 mmol/l of 9-AC as 1 mmol/l 9-AC did not 
increase these changes much further. It must be noted, however, that both 
parameters (phase-1 magnitude and APD90) depend on not only one ionic current, 
but the fine-tuned interplay between several ionic currents, including Ito1, INa, and 
ICa,L in case of phase-1 magnitude and even more in APD90. From our results one 
can draw the conclusion that the application of 9-AC in 0.5 mmol/l dose is suitable 
to examine ICl(Ca) as that dose completely inhibits the chloride current and its 
actions on the morphology of the AP are saturated. 
In conclusion, there was no difference in the actions of DIDS and 9-AC on ICl(Ca) 
examined with standard, rectangular voltage pulses. DIDS however significantly 
blocks fast sodium channels therefore it is not suitable in AP measurements, when 
the investigation focuses on the physiological role of ICl(Ca) in the formation of 
APs. The difference between the action of the blockers on AP is becoming even 
more pronounced at increasing heart rates, resulting in the fact that DIDS but not 
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9-AC fails to demonstrate the frequency-dependent properties of ICl(Ca). One must 
emphasize that DIDS is equally useful to study ICl(Ca) during voltage-clamp when 
INa inhibition is not an issue due to the constant inactivated state of the channels. 
Other major ventricular ion currents (ICa,L, IKr, IKs, and IK1) were not affected by 
9-AC in a dose (0.5 mmol/l) close to that completely blocks chloride channels.  
 
Properties of ICl(Ca) 
In the present study we aimed to characterize ICl(Ca) in isolated canine ventricular 
myocytes under physiological conditions. This included the application of APVC 
allowing to record the current during the physiological AP waveform and using 
pipette solution without buffering of [Ca
2+
]i allowing to develop CaTs with normal 
kinetics. This is critically important in the case of a Ca
2+
-sensitive current, like 
ICl(Ca). Although several studies described ICl(Ca) in various cardiac preparations, the 
properties of ICl(Ca) under true APVC conditions (i.e. when the current is studied 
during an AP recorded from the same myocyte) have not been analyzed.  
The profile of ICl(Ca), when studied as a I9-AC using APVC, was composed of a fast, 
early outward and a late inward component. The outward component showed a 
rapid activation as well as a remarkable rapid decay in spite of the continuously 
elevated [Ca
2+
]i and the existing large driving force for Cl
−
 influx. One possible 
explanation for this rapid decay of ICl(Ca) might be the time dependent inactivation 
of the channels mediating ICl(Ca). It had been shown, however, that in the case of a 
constant [Ca
2+
]i ICl(Ca) showed a time-independent behavior upon prolonged 
depolarization making this option questionable. The same study also suggested the 
existence of a low-affinity Ca
2+
 binding site evoking inactivation of ICl(Ca). The 
possible mechanism for Ca
2+
-dependent inactivation (CDI) was studied in 
TMEM16A channels expressed in HEK cells, where phosphorylation by a Ca
2+
-
calmodulin dependent protein kinase II was suggested. This however is unlikely to 
mediate CDI during the AP. A more likely explanation for the rapid decay of ICl(Ca) 
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may be the rapid and massive reduction of [Ca
2+
]cleft, a change much faster and 
greater than observed with [Ca
2+
]i. This is in line with our results showing co-
localized arrangement of the Ca
2+
 and Cl
−
 channels and allowing a direct guidance 
of ICl(Ca) by [Ca
2+
]cleft, which is strictly controlled by the neighboring Ca
2+
 channels. 
The late inward component in the profile of ICl(Ca) appearing towards the end of the 
AP also needs discussion. According to our hypothesis the current is activated due 
to the combination of membrane potential and an appropriate value of [Ca
2+
]cleft 
which it is still able to activate ICl(Ca) but not too high to cause calmodulin 
dependent inactivation. During terminal repolarization the membrane potential 
reduces below the equilibrium potential of Cl
−
 (−32 mV in our experiments except 
when low [Cl
−
]i was used) therefore an inward current is generated through open 
channels by the efflux of Cl
−
. 
The source of the increase of [Ca
2+
]cleft during diastole can be the spontaneous 
Ca
2+
-release through ryanodine receptors in a Ca
2+
-overloaded cell. The increase of 
[Ca
2+
]cleft can result in formation of arrhythmogenic delayed afterdepolarizations 
(DAD) by forward mode operation of Na
+
/Ca
2+
 exchanger (NCX) and ICl(Ca) 
activation. Activation of ICl(Ca) in canine ventricular cells as well as in ovine 
Purkinje cells and ventricular myocytes was responsible for DAD formation 
highlighting the pathophysiological significance of ICl(Ca). 
However, in a cell without Ca
2+
-overload increase of [Ca
2+
]cleft to a level where it 
can activate ICl(Ca) at the end of the AP is difficult to explain. One option is the 
amplification of the window current of Ca
2+
 channels towards the end of the AP 
due to the growing driving force for Ca
2+
-influx. ICa,L mediated Ca
2+
-influx due to 
the reactivation of L-type Ca
2+
 channels during terminal repolarization was 
observed in guinea-pig ventricular myocytes. In some canine ventricular cells a 
similar late inward peak of INISO measured in normal Ca
2+
 homeostasis was also 
present. 
Another option is the release of Ca
2+
 from myofilaments at the end of the AP 
which is extruded via NCX and might also lead to the activation of ICl(Ca). 
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Experimental evidence exists showing this late activation of forward mode NCX at 
the end of the AP in guinea-pig ventricular cells and also in canine cells. Indeed, 
we have observed similar timing of this inward INCX component and the final 
inward ICl(Ca) recorded in the same cell. 
Moreover, late Na
+
 current is largest towards the late plateau of the AP measured 
in APVC during intact Ca
2+
 homeostasis. This Na
+
-influx slows down the 
previously mentioned Ca
2+
-extrusion via forward mode NCX therefore delays the 
reduction of [Ca
2+
]cleft which might also contribute to the activation of ICl(Ca). 
Finally, the late inward component of ICl(Ca) could be due to the reopening of Cl
−
 
channels at the end of the AP. During the majority of the plateau phase of the AP 
TMEM16A can be inactive because high [Ca
2+
] inactivates TMEM16A via 
calmodulin. Upon the reduction of [Ca
2+
]cleft Ca
2+
 can gradually dissociate from the 
low affinity binding site of calmodulin leading to the suspension of CDI of 
TMEM16A channels. In this scenario [Ca
2+
]cleft can be large enough to activate 
ICl(Ca) but lower than that which causes calmodulin mediated CDI. 
 
Ca
2+
-entry via ICa,L is essential for the activation of ICl(Ca), while Ca
2+
-release from 
SR only augments ICl(Ca) 
Previous studies emphasized the principal role of SR Ca
2+
-release in the activation 
of ICl(Ca) in rabbit atrial myocytes and Purkinje fibers. In contrast, we always 
observed large amplitude of ICl(Ca) in canine myocytes in the continuous perfusion 
of 10 µmol/l ryanodine started 15 min prior to recording. One might argue that 
15 min pretreatment is not enough to achieve the blockade of Ca
2+
-release from SR 
but this is unlikely since both CaTs and cell shortening were largely abolished 
within 8-10 min of ryanodine perfusion. Further possible reason for the observed 
differences in ryanodine-sensitivity of ICl(Ca) might be the different animal model 
used or other differences in experimental conditions. We applied canine ventricular 
cells in the present study in contrast to others using atrial myocytes and Purkinje 
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fibers of the rabbit. It is important to note that 9-AC was capable of decreasing 
phase-1 amplitude even in the presence of ryanodine. Furthermore, the profile of 
ICl(Ca) recorded under APVC conditions in the presence of ryanodine was very 
similar to that seen without ryanodine further confirming that in our experimental 
setting Ca
2+
-release from the SR is not an absolute requirement for the activation 
of ICl(Ca). In contrast to the limited efficacy of ryanodine to eliminate ICl(Ca) in our 
measurements, blockade of Ca
2+
-entry through L-type Ca
2+
 channels by nisoldipine 
fully abolished ICl(Ca).  
Our other experiments support the importance of Ca
2+
-entry through L-type Ca
2+
 
channels further. The amplitude of ICl(Ca) strongly increased when ICa,L was 
enhanced either by ISO or Bay K8644. Both drugs increases ICa,L but as Bay 
K8644 does not phosphorylate channel proteins (unlike what is the case in the 
presence of ISO). However, both treatments increased ICa,L and ICl(Ca) amplitudes to 
the same extent, while the concomitant elevations of CaT amplitudes were not 
proportional.  
In line with this view, increasing the stimulation rate from 1 to 2 Hz also increased 
ICl(Ca) probably due to the increased transsarcolemmal Ca
2+
 entry. 
Co-localization studies have revealed that L-type Ca
2+
 channels and RyRs are in 
close proximity to one another within the dyadic cleft. During excitation-
contraction coupling [Ca
2+
]cleft is believed to be much higher and has faster kinetics 
than in the bulk cytoplasm. However, measuring [Ca
2+
]cleft directly is just 
becoming available. According to our hypothesis, ICl(Ca) is controlled locally, by 
[Ca
2+
]cleft, rather than bulk [Ca
2+
]i. This approach is supported by the experiments 
aiming to set [Ca
2+
]i to 1.1 µmol/l (which corresponds to peak value of systolic 
[Ca
2+
]i) by dialyzing cells with pipette solution containing 1.1 µmol/l of free Ca
2+
. 
In this case, I9-AC amplitude was much smaller, only 13 % of the value obtained 
without buffering [Ca
2+
]i. This is in a good agreement with the Ca
2+
-sensitivity of 
ICl(Ca) determined in murine airway smooth muscle, where the EC50 was estimated 
to be 3.3 µmol/l but only 20-50 µmol/l [Ca2+]i resulted in full activation of the 
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current. Therefore, the significantly larger ICl(Ca) measured under physiological 
conditions, i.e. without buffering [Ca
2+
]i, is probably due to the higher [Ca
2+
]cleft. 
The different actions of EGTA and BAPTA on ICl(Ca) and ICa,L can also be 
explained by the ability of Ca
2+
 chelators to differentially affect [Ca
2+
]i and 
[Ca
2+
]cleft. These agents suppress ICl(Ca) and CDI of ICa,L with different efficacy. 
Although both buffers eliminated CaTs, only BAPTA was effective to suppress 
CDI of ICa,L resulting in significantly higher INISO amplitude and total charge values 
in addition to the much longer AP. BAPTA fully eliminated ICl(Ca) during the AP, 
while EGTA only decreased its amplitude and the total charge carried by the 
current. These results are in a good agreement with the conventional voltage-clamp 
observations. The reason for the different buffering efficacy is that BAPTA has a 
100 times faster binding rate to Ca
2+
 than EGTA. As mentioned previously, 
blockade of Ca
2+
-release from the SR failed to fully abolish ICl(Ca), only some 
reduction of the current amplitude was observed. It is rather difficult, however, to 
judge the relative contribution of Ca
2+
-entry through L-type Ca
2+
 channels and 
Ca
2+
-release from SR to the activation of ICl(Ca). One reason is that the CDI of ICa,L 
is known to be reduced when Ca
2+
-release from SR is blocked (e.g. in the presence 
of ryanodine). Therefore the relative contribution of L-type Ca
2+
 channels to ICl(Ca) 
activation is probably overestimated in the presence of ryanodine. Determining the 
precise contribution of these two mechanisms is further complicated by the 
presence of several other Ca
2+
-dependent processes involved in the ventricular 
electrical activity, including the NCX, Ca
2+
-dependent K
+
 channels, and various 
Ca
2+
 pumps, likely to be altered by changes in [Ca
2+
]i and even more by alterations 
in [Ca
2+
]cleft.  
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Co-localization of Cav1.2 with TMEM16A and Bestrophin-3 proteins, possible 
contributors of ICl(Ca) 
In this study we tested the co-localization of Bestrophin-3 and/or TMEM16A, the 
two likely candidates responsible for ICl(Ca), with Cav1.2 protein. The expression of 
Bestrophin-1 and Bestrophin-3 was demonstrated in murine heart. Moreover, when 
Bestrophin-1 or Bestrophin-3 were extracted and transfected to HEK cells, the 
resultant current recapitulated the characteristics of ICl(Ca), including Ca
2+
-
dependence, anion selectivity and sensitivity to DIDS or niflumic acid. The same 
group reported the expression of Bestrophin-3 in human heart (although only at 
mRNA level in the latter) similarly to Bestrophin-1. The cellular expression of 
Bestrophin-3 in murine ventricular cells showed a punctuated pattern which was 
strong in the sarcolemma. In our images obtained in canine and human ventricular 
myocytes the cellular expression of Bestrophin-3 showed striated pattern rather 
than being punctuated.  
Cardiac expression of TMEM16A has been described in murine ventricle, but this 
is the first report demonstrating it in canine and human ventricular preparations. In 
both species a clear-cut striated pattern was observed. Importantly, the expression 
of Bestrophin-3 showed strong co-localization with Cav1.2 channel protein and 
TMEM16A making it very likely that Cav1.2 and TMEM16A also co-localize with 
one another. In line with the results of the present study Ca
2+
-activated Cl
−
 
channels localize close to RyR and are controlled by local Ca
2+
 signals in airway 
smooth muscle. Bestrophins can associate with TMEM16A and contribute to the 
functional channel in vascular smooth muscle cells. This possibility, however, is 
very difficult to test since TMEM16A modulates Bestrophin expression. Down-
regulation of TMEM16A reduced the expression of Bestrophins, however, a 
reduced expression of L-type Ca
2+
 channels has also been mentioned. On the other 
hand, Bestrophins were shown to form preferentially homomer channels, similarly 
to TMEM16A, which may question the ability of the two proteins to form a single 
functional ion channel. 
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The striated pattern of TMEM16A, Bestrophin-3, and Cav1.2 expression is most 
likely due to the strong expression of these proteins in the membranes of the t-
tubules. Similar images were published in murine and human ventricular 
cardiomyocytes with Cav1.2 expression in the t-tubules. The accidental co-
localization of the channel proteins due to technical factors of imaging is unlikely 
since the co-localization of TMEM16A with cytochrome c was weak. Similarly, 
less pronounced co-localization was seen between Bestrophin-3 and RyR than 
between Bestrophin-3 and TMEM16A/Cav1.2. The expression pattern of RyR was 
very similar to that seen in rat ventricular myocytes.  
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Summary 
Understanding the role of ionic currents in shaping the cardiac action potential 
(AP) has great importance as channel malfunctions can lead to sudden cardiac 
death by inducing arrhythmias. Despite the possible contribution of (ICl(Ca)) may 
mediated by TMEM16A and/or Bestrophin-3 to cardiac arrhythmias, the true 
profile of ICl(Ca) during an actual ventricular AP, is poorly understood.  
In this study we aimed to explore which blocker, 4,4’-diisothiocyanostilbene-2,2’-
disulfonic acid (DIDS) or 9-anthracene carboxylic acid (9-AC) is preferable to 
visualize the profile of ICl(Ca). We aimed to study ICl(Ca) at normal Ca
2+
 cycling and 
by AP voltage-clamp as well as in conditions designed to change [Ca
2+
]i in canine 
ventricular myocytes. The expression of TMEM16A and/or Bestrophin-3 in canine 
left ventricular myocytes and human ventricular myocardium by immunolabelling 
was examined. The possible spatial distribution of these proteins and their co-
localization with Cav1.2 was also studied. 
Both inhibitors, DIDS (0.2 mmol/l) and 9-AC (0.5 mmol/l) increased AP duration. 
DIDS- and 9-AC-sensitive currents were identical in voltage-clamp conditions. 
9-AC did not influence either the AP amplitude or the maximal rate of 
depolarizations (Vmax), while DIDS caused marked reduction of Vmax. The profile 
of ICl(Ca), identified as a 9-AC-sensitive current under AP voltage-clamp conditions, 
contained an early fast outward and a late inward component, overlapping early 
and terminal repolarizations, respectively. Both components were moderately 
reduced by ryanodine, while fully abolished by BAPTA, but not EGTA. Setting 
[Ca
2+
]i to the systolic level measured in the bulk cytoplasm (1.1 µmol/l) decreased 
ICl(Ca). Increase in [Ca
2+
]i elicited by application of BayK 8644, isoproterenol, and 
faster stimulation rates increased the amplitude of ICl(Ca). We concluded that Ca
2+
-
entry through L-type Ca
2+
 channels is essential for activation of ICl(Ca). TMEM16A 
and Bestrophin-3 showed strong co-localization with one another and also with 
Cav1.2 channels, when assessed using immunolabelling and confocal microscopy 
in both canine myocytes and human ventricular myocardium. 
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These results suggest that DIDS and 9-AC are equally useful to study ICl(Ca) during 
voltage-clamp but 9-AC is superior in AP due to its lack of sodium channel 
inhibition. Activation of ICl(Ca) in canine ventricular cells requires Ca
2+
-entry 
through neighboring L-type Ca
2+
 channels and is only augmented by SR Ca
2+
-
release. Substantial activation of ICl(Ca) requires high Ca
2+
 in the dyadic clefts 
which can be effectively buffered by BAPTA, but not EGTA. 
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